miR-184 was also found to be downregulated in ccRCC tissues and directly targeted Cyclin D1 (CCND1), a key regulator of the cell cycle, further confirming its tumour-suppressive function [47]. This evidence concerns the gene CCND1 and nonpapillary renal cell carcinoma.